Mir-106 too was described as deeply involved in TGFβ protumorigenic signaling through targeting of SMAD7, in turn inducing EMT in breast cancer [59], similarly to miR-10b, induced by TGFβ1 and promoting EMT in breast cancer [60]. Here, SMAD7 is linked to breast cancer.